We hypothesize that this may be the reason why humans carrying the A53T or even overexpression (duplication or triplication of the wild-type SNCA gene) develops PD pathology at a significantly earlier time than seen in idiopathic or even other familial forms of Parkinson’s disease. The gene discussed is SNCA; the disease is Parkinson disease.